<DOC>
	<DOC>NCT01119716</DOC>
	<brief_summary>This study will create a prospective registry of consecutive patients with Atrial Fibrillation (Afib) considered for cardioversion treatment to document up-to-date practice of in-hospital treatment, with a focus on the characterization of type of Afib, as well as on treatments applied (drugs, devices, interventions and their combinations), and associated complications within 60 days after enrollment.</brief_summary>
	<brief_title>International Registry on Cardioversion of Atrial Fibrillation (MK-6621-051)</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Participant with documented atrial fibrillation (confirmed by electrocardiogram) in the hospital setting at the time of enrollment Planned cardioversion (of atrial fibrillation) Already enrolled in this or any other clinical trial Atrial flutter</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Afib</keyword>
	<keyword>cardioversion</keyword>
	<keyword>normal sinus rhythm</keyword>
	<keyword>arrhythmia</keyword>
	<keyword>AF</keyword>
</DOC>